Optimal cross-linking outcomes

Optimal cross-linking outcomes
Dermot McGrath
Dermot McGrath
Published: Sunday, September 23, 2018
Respecting certain technical parameters in the application of corneal collagen cross-linking (CXL) will help physicians achieve greater consistency in outcomes when treating patients with keratoconus, Theo Seiler MD told delegates attending the joint ESCRS/EuCornea symposium on cross-linking. Since the introduction of CXL into clinics, many changes to the original Dresden protocol have been proposed, such as new light sources with shorter treatment times due to higher irradiances and new solutions with shorter imbibition times. “I think it is a good opportunity today to answer some of the questions that my colleagues frequently ask about the application of CXL in their clinics – how much energy to use, as well as questions around oxygen and riboflavin use,” he said. In terms of ultraviolet parameters, Dr Seiler said that lamps on the international market now offer UV-irradiances ranging from 3 mW/cm2 to 45 mW/cm2. However, using higher UV doses combined with shorter treatment times will reduce the efficacy of the treatment, said Dr Seiler. “Shorter operation times may be achieved by increasing the irradiance from 3mW/cm2 up to 15mW/cm2 without loss of efficacy if the application time is adjusted. The application of riboflavin in HPMC-solution shortens inhabitation time from 30 minutes to 10 minutes,” he said. For effective cross-linking to occur, a certain amount of oxygen is required to be present in the cornea, said Dr Seiler. Whereas the standard Dresden protocol occurs slowly enough for the oxygen to replenish, some accelerated CXL protocols consume too much oxygen too quickly.
Tags: corneal crosslinking
Latest Articles
ESCRS Today 2025: Happy Anniversaries!

ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.

Read more...

ESCRS Today 2025: A Congress for Everyone

From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.

Read more...

ESCRS Today 2025: All Eyes on Innovation

Watching out for obstacles and opportunities

Read more...

Beyond the Numbers

Empowering patient participation fosters continuous innovation in cataract surgery.

Read more...

Thinking Beyond the Surgery Room

Practice management workshop focuses on financial operations and AI business applications.

Read more...

Aid Cuts Threaten Global Eye Care Progress

USAID closure leads retreat in development assistance.

Read more...

Supplement: ESCRS Clinical Trends Series: Presbyopia

Read more...

Debate: FS-LASIK or KLEx for Hyperopia?

FS-LASIK has more of a track record, but KLEx offers advantages.

Read more...

Four AI Applications Ready for Practice

Commercial offerings may save time, improve practice and research.

Read more...

Perioperative Medication Regimens for Cataract Surgery

Randomised controlled clinical trial results provide evidence-based guidance.

Read more...